We’ll see where it goes. Mass customization is not bad, it’s just not actual personalization in terms of cancer, for every patient. It looks like it and they are dressing it up nicely, but it is a very particular and indirect way of doing it and probably the only way you can get close to personalization with the mRNA. As I said, I wish them well, and they will add another tool for a variety of cancers, no doubt.
Market Data 
Markets 
AI
